ETOPOSIDE INJECTION, USP
ETOPOSIDE INJECTION, USP
Dormant
DIN Number
02422530
Drug Class
Human
Market Date
Jul 10, 2014
Company
HC
Strides Pharma Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02422530
AIG Number0114567002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ETOPOSIDEActive
Strength: 20 MG / ML
Monograph: ETOPOSIDE